BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coffin CS, Lee SS. New paradigms in hepatitis B management: only diamonds are forever. Br Med Bull 2015;116:79-91. [PMID: 26377741 DOI: 10.1093/bmb/ldv039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Dawood A, Abdul Basit S, Jayaraj M, Gish RG. Drugs in Development for Hepatitis B. Drugs 2017;77:1263-80. [PMID: 28660478 DOI: 10.1007/s40265-017-0769-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
2 Osiowy C, Coffin C, Andonov A. Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Curr Treat Options Infect Dis 2016;8:177-93. [PMID: 27547127 DOI: 10.1007/s40506-016-0080-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Hao Z, Biqing Z, Ling Y, Wenting Z. The Effectiveness of Antiviral Treatments for Patients with HBeAg-Positive Chronic Hepatitis B: A Bayesian Network Analysis. Can J Gastroenterol Hepatol 2018;2018:3576265. [PMID: 30276197 DOI: 10.1155/2018/3576265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Xu J, Xu Z, Zheng W. A Review of the Antiviral Role of Green Tea Catechins. Molecules. 2017;22:pii: E1337. [PMID: 28805687 DOI: 10.3390/molecules22081337] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
5 Scott LJ, Chan HLY. Tenofovir Alafenamide: A Review in Chronic Hepatitis B. Drugs. 2017;77:1017-1028. [PMID: 28493172 DOI: 10.1007/s40265-017-0754-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]